Literature DB >> 21346001

Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words.

Hans C Lou1, Joshua C Skewes, Kristine Rømer Thomsen, Morten Overgaard, Hakwan C Lau, Kim Mouridsen, Andreas Roepstorff.   

Abstract

Liberal acceptance, overconfidence, and increased activity of the neurotransmitter dopamine have been proposed to account for abnormal sensory experiences, for instance, hallucinations in schizophrenia. In normal subjects, increased sensory experience in Yoga Nidra meditation is linked to striatal dopamine release. We therefore hypothesize that the neurotransmitter dopamine may function as a regulator of subjective confidence of visual perception in the normal brain. Although much is known about the effect of stimulation by neurotransmitters on cognitive functions, their effect on subjective confidence of perception has never been recorded experimentally before. In a controlled study of 24 normal, healthy female university students with the dopamine agonist pergolide given orally, we show that dopaminergic activation increases confidence in seeing rapidly presented words. It also improves performance in a forced-choice word recognition task. These results demonstrate neurotransmitter regulation of subjective conscious experience of perception and provide evidence for a crucial role of dopamine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346001     DOI: 10.1167/11.2.15

Source DB:  PubMed          Journal:  J Vis        ISSN: 1534-7362            Impact factor:   2.240


  18 in total

1.  Ready steady slow: action preparation slows the subjective passage of time.

Authors:  Nobuhiro Hagura; Ryota Kanai; Guido Orgs; Patrick Haggard
Journal:  Proc Biol Sci       Date:  2012-09-05       Impact factor: 5.349

2.  A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine.

Authors:  Clifford M Cassidy; Peter D Balsam; Jodi J Weinstein; Rachel J Rosengard; Mark Slifstein; Nathaniel D Daw; Anissa Abi-Dargham; Guillermo Horga
Journal:  Curr Biol       Date:  2018-02-02       Impact factor: 10.834

3.  Cognitive Neurostimulation: Learning to Volitionally Sustain Ventral Tegmental Area Activation.

Authors:  Jeff J MacInnes; Kathryn C Dickerson; Nan-Kuei Chen; R Alison Adcock
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

4.  Impact of emotion on consciousness: positive stimuli enhance conscious reportability.

Authors:  Kristine Rømer Thomsen; Hans C Lou; Morten Joensson; Jonathan A Hyam; Peter Holland; Christine E Parsons; Katherine S Young; Arne Møller; Alan Stein; Alex L Green; Morten L Kringelbach; Tipu Z Aziz
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

5.  Perception of biological motion in schizophrenia and healthy individuals: a behavioral and FMRI study.

Authors:  Jejoong Kim; Sohee Park; Randolph Blake
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

6.  An interoceptive predictive coding model of conscious presence.

Authors:  Anil K Seth; Keisuke Suzuki; Hugo D Critchley
Journal:  Front Psychol       Date:  2012-01-10

7.  Yoga lessons for consciousness research: a paralimbic network balancing brain resource allocation.

Authors:  Hans C Lou; Morten Joensson; Morten L Kringelbach
Journal:  Front Psychol       Date:  2011-12-16

8.  Associations between visual perception accuracy and confidence in a dopaminergic manipulation study.

Authors:  Christina Andreou; Vasilis P Bozikas; Thies Luedtke; Steffen Moritz
Journal:  Front Psychol       Date:  2015-04-16

9.  Eluding the illusion? Schizophrenia, dopamine and the McGurk effect.

Authors:  Thomas P White; Rebekah L Wigton; Dan W Joyce; Tracy Bobin; Christian Ferragamo; Nisha Wasim; Stephen Lisk; Sukhwinder S Shergill
Journal:  Front Hum Neurosci       Date:  2014-08-05       Impact factor: 3.169

10.  Exogenous dopamine reduces GABA receptor availability in the human brain.

Authors:  Hans C Lou; Astrid Rosenstand; David J Brooks; Dirk Bender; Steen Jakobsen; Jakob U Blicher; Kim V Hansen; Arne Møller
Journal:  Brain Behav       Date:  2016-05-05       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.